 | | OGZ | | 表記: | [3-(trifluoromethyl)phenyl]methanamine | | 組成式: | C8 H8 F3 N | | SMILES: | NCc1cccc(c1)C(F)(F)F | | InChi: | InChI=1S/C8H8F3N/c9-8(10,11)7-3-1-2-6(4-7)5-12/h1-4H,5,12H2 | | 定義日: | 2020-03-09 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-03-31 | | 識別子(ID): | [3-(trifluoromethyl)phenyl]methanamine |
|
 | | TCQ | | 表記: | (1S,2R)-N-{(1E)-5-[(2S)-2-amino-2-carboxyethyl]-2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene}-2-phenylcyclopropanaminium | | 組成式: | C18 H19 N2 O4 | | SMILES: | O=C(O)C(N)CC=3C(=O)C=C(O)C(=[NH+]C2CC2c1ccccc1)C=3 | | InChi: | InChI=1S/C18H18N2O4/c19-13(18(23)24)6-11-7-15(17(22)9-16(11)21)20-14-8-12(14)10-4-2-1-3-5-10/h1-5,7,9,12-14,22H,6,8,19H2,(H,23,24)/p+1/b20-15+/t12-,13+,14+/m1/s1 | | 定義日: | 2004-07-27 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (1S,2R)-N-{(1E)-5-[(2S)-2-amino-2-carboxyethyl]-2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene}-2-phenylcyclopropanaminium |
|
 | | QJN | | 表記: | (1~{R},2~{S},4~{R},5~{S},6~{R})-6-[(2~{S},3~{R},4~{R},5~{S},6~{R})-5-heptoxy-6-(hydroxymethyl)-3,4-bis(oxidanyl)oxan-2-yl]oxy-5-(hydroxymethyl)cyclohexane-1,2,4-triol | | 組成式: | C20 H38 O10 | | SMILES: | CCCCCCCO[CH]1[CH](O)[CH](O)[CH](O[CH]1CO)O[CH]2[CH](O)[CH](O)C[CH](O)[CH]2CO | | InChi: | InChI=1S/C20H38O10/c1-2-3-4-5-6-7-28-19-14(10-22)29-20(17(27)16(19)26)30-18-11(9-21)12(23)8-13(24)15(18)25/h11-27H,2-10H2,1H3/t11-,12+,13-,14+,15+,16+,17+,18+,19+,20+/m0/s1 | | 定義日: | 2020-06-18 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-02-10 | | 識別子(ID): | (1~{R},2~{S},4~{R},5~{S},6~{R})-6-[(2~{S},3~{R},4~{R},5~{S},6~{R})-5-heptoxy-6-(hydroxymethyl)-3,4-bis(oxidanyl)oxan-2-yl]oxy-5-(hydroxymethyl)cyclohexane-1,2,4-triol |
|
 | | TS9 | | 表記: | (2S,3S,4R)-2-amino-3,4-dihydroxy-3-methylpentanoic acid | | 組成式: | C6 H13 N O4 | | SMILES: | O=C(O)C(N)C(O)(C)C(O)C | | InChi: | InChI=1S/C6H13NO4/c1-3(8)6(2,11)4(7)5(9)10/h3-4,8,11H,7H2,1-2H3,(H,9,10)/t3-,4-,6-/m1/s1 | | 定義日: | 2008-03-11 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (2S,3S,4R)-2-amino-3,4-dihydroxy-3-methylpentanoic acid (non-preferred name) |
|
 | | MU9 | | 表記: | 2-chloranyl-~{N}-[[1-[1-[(4-chlorophenyl)amino]-4,4-bis(fluoranyl)cyclohexyl]carbonylpiperidin-4-yl]methyl]ethanamide | | 組成式: | C21 H27 Cl2 F2 N3 O2 | | SMILES: | FC1(F)CCC(CC1)(Nc2ccc(Cl)cc2)C(=O)N3CCC(CC3)CNC(=O)CCl | | InChi: | InChI=1S/C21H27Cl2F2N3O2/c22-13-18(29)26-14-15-5-11-28(12-6-15)19(30)20(7-9-21(24,25)10-8-20)27-17-3-1-16(23)2-4-17/h1-4,15,27H,5-14H2,(H,26,29) | | 定義日: | 2022-08-04 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-09-20 | | 識別子(ID): | 2-chloranyl-~{N}-[[1-[1-[(4-chlorophenyl)amino]-4,4-bis(fluoranyl)cyclohexyl]carbonylpiperidin-4-yl]methyl]ethanamide |
|
 | | RBL | | 表記: | D-ribulose | | 組成式: | C5 H10 O5 | | SMILES: | O=C(CO)C(O)C(O)CO | | InChi: | InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m1/s1 | | 定義日: | 2009-01-26 | | 最終更新日: | 2024-09-27 | | 公開日: | 2013-11-27 | | 識別子(ID): | D-ribulose |
|
 | | 8PW | | 表記: | (2S,4R)-N-(1-cyanocyclopropyl)-1-(1-methylcyclopropanecarbonyl)-4-[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonylpyrrolidine-2-carboxamide | | 組成式: | C23 H25 F6 N3 O5 S | | SMILES: | O=S(=O)(c1ccc(OCC(F)(F)F)cc1C(F)(F)F)C4CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C3(C)CC3)C4 | | InChi: | InChI=1S/C23H25F6N3O5S/c1-20(4-5-20)19(34)32-10-14(9-16(32)18(33)31-21(11-30)6-7-21)38(35,36)17-3-2-13(37-12-22(24,25)26)8-15(17)23(27,28)29/h2-3,8,11,14,16,30H,4-7,9-10,12H2,1H3,(H,31,33)/b30-11+/t14-,16+/m1/s1 | | 定義日: | 2013-06-03 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-06-18 | | 識別子(ID): | (4R)-N-{1-[(E)-iminomethyl]cyclopropyl}-1-[(1-methylcyclopropyl)carbonyl]-4-{[4-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)phenyl]sulfonyl}-L-prolinamide |
|
 | | U6Y | | 表記: | benzyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-5-oxopyrrolidin-3-yl}carbamate | | 組成式: | C29 H41 N5 O7 | | SMILES: | CC(C)CC(C(=O)NC(CC1CCNC1=O)C(O)C(=O)NC1CC1)N1CC(CC1=O)NC(=O)OCc1ccccc1 | | InChi: | InChI=1S/C29H41N5O7/c1-17(2)12-23(34-15-21(14-24(34)35)32-29(40)41-16-18-6-4-3-5-7-18)27(38)33-22(13-19-10-11-30-26(19)37)25(36)28(39)31-20-8-9-20/h3-7,17,19-23,25,36H,8-16H2,1-2H3,(H,30,37)(H,31,39)(H,32,40)(H,33,38)/t19-,21-,22-,23-,25+/m0/s1 | | 定義日: | 2022-08-08 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-04-05 | | 識別子(ID): | benzyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-5-oxopyrrolidin-3-yl}carbamate |
|
 | | MUB | | 表記: | N-acetyl-alpha-muramic acid | | 組成式: | C11 H19 N O8 | | SMILES: | O=C(O)C(OC1C(O)C(OC(O)C1NC(=O)C)CO)C | | InChi: | InChI=1S/C11H19NO8/c1-4(10(16)17)19-9-7(12-5(2)14)11(18)20-6(3-13)8(9)15/h4,6-9,11,13,15,18H,3H2,1-2H3,(H,12,14)(H,16,17)/t4-,6-,7-,8-,9-,11+/m1/s1 | | 別名: | N-acetyl-muramic acid | | 定義日: | 2004-03-16 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 2-(acetylamino)-3-O-[(1R)-1-carboxyethyl]-2-deoxy-alpha-D-glucopyranose |
|
 | | SJK | | 表記: | 5-oxidanylidene-~{N}-(2-sulfanylethyl)-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide | | 組成式: | C9 H11 N3 O2 S2 | | SMILES: | SCCNC(=O)C1=CN=C2SCCN2C1=O | | InChi: | InChI=1S/C9H11N3O2S2/c13-7(10-1-3-15)6-5-11-9-12(8(6)14)2-4-16-9/h5,15H,1-4H2,(H,10,13) | | 定義日: | 2020-11-17 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-12-09 | | 識別子(ID): | 5-oxidanylidene-~{N}-(2-sulfanylethyl)-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide |
|
 | | OXD | | 表記: | OXALIC ACID | | 組成式: | C2 H2 O4 | | SMILES: | O=C(O)C(=O)O | | InChi: | InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6) | | 定義日: | 2003-06-20 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | ethanedioic acid |
|
 | | OXE | | 表記: | ORTHO-XYLENE | | 組成式: | C8 H10 | | SMILES: | c1cccc(c1C)C | | InChi: | InChI=1S/C8H10/c1-7-5-3-4-6-8(7)2/h3-6H,1-2H3 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 1,2-dimethylbenzene |
|
 | | 8Q1 | | 表記: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate | | 組成式: | C23 H45 N2 O8 P S | | SMILES: | O=C(CCCCCCCCCCC)SCCNC(CCNC(C(C(COP(=O)(O)O)(C)C)O)=O)=O | | InChi: | InChI=1S/C23H45N2O8PS/c1-4-5-6-7-8-9-10-11-12-13-20(27)35-17-16-24-19(26)14-15-25-22(29)21(28)23(2,3)18-33-34(30,31)32/h21,28H,4-18H2,1-3H3,(H,24,26)(H,25,29)(H2,30,31,32)/t21-/m0/s1 | | 別名: | S-dodecanoyl-4'-phosphopantetheine | | 定義日: | 2017-02-28 | | 最終更新日: | 2024-09-27 | | 公開日: | 2017-06-21 | | 識別子(ID): | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate |
|
 | | M1M | | 表記: | 1,1-Methanediyl Bismethanethiosulfonate | | 組成式: | C3 H8 O4 S4 | | SMILES: | S(S(=O)(=O)C)CSS(=O)(=O)C | | InChi: | InChI=1S/C3H8O4S4/c1-10(4,5)8-3-9-11(2,6)7/h3H2,1-2H3 | | 別名: | S,S'-methylene dimethanesulfonothioate | | 定義日: | 2016-05-12 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-05-27 | | 識別子(ID): | S,S'-methylene dimethanesulfonothioate |
|
 | | TCX | | 表記: | ethylphosphoramidic acid | | 組成式: | C2 H8 N O3 P | | SMILES: | O=P(O)(O)NCC | | InChi: | InChI=1S/C2H8NO3P/c1-2-3-7(4,5)6/h2H2,1H3,(H3,3,4,5,6) | | 定義日: | 2009-05-12 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | ethylphosphoramidic acid |
|
 | | M1N | | 表記: | (1R)-3-METHYL-1-{[N-(MORPHOLIN-4-YLCARBONYL)-3-(1-NAPHTHYL)-D-ALANYL]AMINO}BUTYLBORONIC ACID | | 組成式: | C23 H32 B N3 O5 | | SMILES: | O=C(NC(C(=O)NC(B(O)O)CC(C)C)Cc2c1ccccc1ccc2)N3CCOCC3 | | InChi: | InChI=1S/C23H32BN3O5/c1-16(2)14-21(24(30)31)26-22(28)20(25-23(29)27-10-12-32-13-11-27)15-18-8-5-7-17-6-3-4-9-19(17)18/h3-9,16,20-21,30-31H,10-15H2,1-2H3,(H,25,29)(H,26,28)/t20-,21+/m1/s1 | | 別名: | N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID | | 定義日: | 2006-01-10 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | [(1R)-3-methyl-1-({(2R)-2-[(morpholin-4-ylcarbonyl)amino]-3-naphthalen-1-ylpropanoyl}amino)butyl]boronic acid (non-preferred name) |
|
 | | RBS | | 表記: | N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE | | 組成式: | C17 H14 N4 O | | SMILES: | O=C(/C=C)Nc3cc1c(ncnc1Nc2ccccc2)cc3 | | InChi: | InChI=1S/C17H14N4O/c1-2-16(22)20-13-8-9-15-14(10-13)17(19-11-18-15)21-12-6-4-3-5-7-12/h2-11H,1H2,(H,20,22)(H,18,19,21) | | 定義日: | 2006-08-02 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | N-[4-(phenylamino)quinazolin-6-yl]prop-2-enamide |
|
 | | OXJ | | 表記: | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine | | 組成式: | C10 H9 F6 N | | SMILES: | CNCc1cc(cc(c1)C(F)(F)F)C(F)(F)F | | InChi: | InChI=1S/C10H9F6N/c1-17-5-6-2-7(9(11,12)13)4-8(3-6)10(14,15)16/h2-4,17H,5H2,1H3 | | 定義日: | 2019-07-15 | | 最終更新日: | 2024-09-27 | | 公開日: | 2019-12-11 | | 識別子(ID): | 1-[3,5-bis(trifluoromethyl)phenyl]-N-methylmethanamine |
|
 | | Q5O | | 表記: | ~{N}3-[4-[bis(fluoranyl)methoxy]-2-methyl-phenyl]-4-chloranyl-6-fluoranyl-~{N}1-[(4-fluorophenyl)methyl]benzene-1,3-dicarboxamide | | 組成式: | C23 H17 Cl F4 N2 O3 | | SMILES: | Cc1cc(OC(F)F)ccc1NC(=O)c2cc(c(F)cc2Cl)C(=O)NCc3ccc(F)cc3 | | InChi: | InChI=1S/C23H17ClF4N2O3/c1-12-8-15(33-23(27)28)6-7-20(12)30-22(32)16-9-17(19(26)10-18(16)24)21(31)29-11-13-2-4-14(25)5-3-13/h2-10,23H,11H2,1H3,(H,29,31)(H,30,32) | | 定義日: | 2022-10-14 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-12-28 | | 識別子(ID): | ~{N}3-[4-[bis(fluoranyl)methoxy]-2-methyl-phenyl]-4-chloranyl-6-fluoranyl-~{N}1-[(4-fluorophenyl)methyl]benzene-1,3-dicarboxamide |
|
 | | OHD | | 表記: | {(4Z)-2-[(1S)-1-aminoethyl]-4-[(3-chloro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | | 組成式: | C14 H14 Cl N3 O4 | | SMILES: | NC(C)C1=N/C(C(N1CC(O)=O)=O)=Cc2ccc(c(c2)Cl)O | | InChi: | InChI=1S/C14H14ClN3O4/c1-7(16)13-17-10(14(22)18(13)6-12(20)21)5-8-2-3-11(19)9(15)4-8/h2-5,7,19H,6,16H2,1H3,(H,20,21)/b10-5-/t7-/m0/s1 | | 別名: | PEPTIDE DERIVED CHROMOPHORE | | 定義日: | 2019-06-25 | | 最終更新日: | 2024-09-27 | | 公開日: | 2019-08-07 | | 識別子(ID): | {(4Z)-2-[(1S)-1-aminoethyl]-4-[(3-chloro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | | PBA | | 表記: | PHENYLETHANE BORONIC ACID | | 組成式: | C8 H11 B O2 | | SMILES: | OB(O)CCc1ccccc1 | | InChi: | InChI=1S/C8H11BO2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-5,10-11H,6-7H2 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (2-phenylethyl)boronic acid |
|
 | | M1R | | 表記: | 1-{4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl}propan-1-one | | 組成式: | C30 H38 N6 O2 | | SMILES: | c5(N2Cc3nc(nc(N1CCN(CC1)C(CC)=O)c3CC2)OCC4N(C)CCC4)cccc6c5cccc6 | | InChi: | InChI=1S/C30H38N6O2/c1-3-28(37)34-16-18-35(19-17-34)29-25-13-15-36(27-12-6-9-22-8-4-5-11-24(22)27)20-26(25)31-30(32-29)38-21-23-10-7-14-33(23)2/h4-6,8-9,11-12,23H,3,7,10,13-21H2,1-2H3/t23-/m0/s1 | | 定義日: | 2019-10-31 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-04-22 | | 識別子(ID): | 1-{4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl}propan-1-one |
|
 | | U76 | | 表記: | (3,5-difluorophenyl)methyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate | | 組成式: | C30 H41 F2 N5 O7 | | SMILES: | O=C1NCCC1CC(NC(=O)C(CC(C)C)N1CC(CCC1=O)NC(=O)OCc1cc(F)cc(F)c1)C(O)C(=O)NC1CC1 | | InChi: | InChI=1S/C30H41F2N5O7/c1-16(2)9-24(28(41)36-23(12-18-7-8-33-27(18)40)26(39)29(42)34-21-3-4-21)37-14-22(5-6-25(37)38)35-30(43)44-15-17-10-19(31)13-20(32)11-17/h10-11,13,16,18,21-24,26,39H,3-9,12,14-15H2,1-2H3,(H,33,40)(H,34,42)(H,35,43)(H,36,41)/t18-,22-,23-,24-,26+/m0/s1 | | 定義日: | 2022-08-08 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-04-05 | | 識別子(ID): | (3,5-difluorophenyl)methyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate |
|
 | | TSL | | 表記: | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | | 組成式: | C8 H13 N O5 S | | SMILES: | O=S(O)C(C(NC=CC=O)C(=O)O)(C)C | | InChi: | InChI=1S/C8H13NO5S/c1-8(2,15(13)14)6(7(11)12)9-4-3-5-10/h3-6,9H,1-2H3,(H,11,12)(H,13,14)/b4-3+/t6-/m0/s1 | | 定義日: | 2005-07-28 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine |
|
 | | PBC | | 表記: | PHENYL BORONIC ACID | | 組成式: | C6 H7 B O2 | | SMILES: | OB(O)c1ccccc1 | | InChi: | InChI=1S/C6H7BO2/c8-7(9)6-4-2-1-3-5-6/h1-5,8-9H | | 定義日: | 2001-08-29 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | phenylboronic acid |
|